Vasodilation

Source: Wikipedia, the free encyclopedia.
(Redirected from
Vasodilator
)

Normal blood vessel (left) vs. vasodilation (right)

Vasodilation, also known as vasorelaxation, is the widening of blood vessels.[1] It results from relaxation of smooth muscle cells within the vessel walls, in particular in the large veins, large arteries, and smaller arterioles.[2] Blood vessel walls are composed of endothelial tissue and a basal membrane lining the lumen of the vessel, concentric smooth muscle layers on top of endothelial tissue, and an adventitia over the smooth muscle layers.[3] Relaxation of the smooth muscle layer allows the blood vessel to dilate, as it is held in a semi-constricted state by sympathetic nervous system activity.[2] Vasodilation is the opposite of vasoconstriction, which is the narrowing of blood vessels.

When blood vessels

flow of blood is increased due to a decrease in vascular resistance and increase in cardiac output[further explanation needed]. Vascular resistance is the amount of force circulating blood must overcome in order to allow perfusion of body tissues. Narrow vessels create more vascular resistance, while dilated vessels decrease vascular resistance. Vasodilation acts to increase cardiac output by decreasing afterload, −one of the four determinants of cardiac output.[4]

By expanding available area for blood to circulate, vasodilation decreases

Endogenous substances and drugs that cause vasodilation are termed vasodilators. Many of these substances are neurotransmitters released by perivascular nerves of the autonomic nervous system[6] Baroreceptors sense blood pressure and allow adaptation via the mechanisms of vasoconstriction or vasodilation to maintain homeostasis.[2]

Function

The primary function of vasodilation is to increase blood flow in the body to tissues that need it most. This is often in response to a localized

mutually exclusive.[10]

Immune system

Vasodilation plays a major role in immune system function. Wider blood vessels allow more blood containing immune cells and proteins to reach the infection site. Vasodilation occurs as part of the process of inflammation, which is caused by several factors including presence of a pathogen, injury to tissues or blood vessels, and immune complexes.[7] In severe cases, inflammation can lead to sepsis or distributive shock.[11] Vasodilation is also a major component of anaphylaxis.[12]

Inflammation causes not only vasodilation but also causes increased

antibodies to reach the site of infection or damage.[7] Elevated vascular permeability can allow excess fluid to leave blood vessels and collect in tissues resulting in edema; vasodilation prevents blood vessels from constricting to adapt to reduced volume in the vessels, causing low blood pressure and septic shock.[11]

In the case of inflammation, vasodilation is caused by

complement proteins C3a and C5a, bind to receptors on mast cells and basophils causing degranulation.[12] Granules in these cells contain histamine, platelet-activating factor, and other compounds causing clinical manifestation of anaphylaxis- including systemic vasodilation causing dangerously low blood pressure.[12] Immunoglobulin E, an antibody produced by plasma cells, also binds to receptors on mast cells and basophils causing degranulation.[12]

Mechanism

A basic understanding of

Vascular resistance depends on several factors, including the length of the vessel, the viscosity of blood (determined by hematocrit) and the diameter of the blood vessel.[18] The latter is the most important variable in determining resistance, with the vascular resistance changing by the fourth power of the radius.[2] An increase in either of these physiological components (cardiac output or vascular resistance) causes a rise in MAP. Arterioles create the most vascular resistance of any blood vessel type, as they are very narrow and possess concentric layers of smooth muscle unlike venules and capillaries.[2]

Vasodilation occurs in superficial blood vessels of

epinephrine, respectively.[19][20]

Smooth muscle physiology

The

Rho-kinase prevents it from binding to and dephosphorylating the myosin light-chain, allowing the cell to remain contracted.[22]

Vasodilation is the result of relaxation in

calcium ions out of the intracellular compartment both contribute to smooth muscle cell relaxation and therefore vasodilation. This is accomplished through reuptake of ions into the sarcoplasmic reticulum via exchangers and expulsion across the plasma membrane.[23] There are three main intracellular stimuli that can result in the vasodilation of blood vessels. The specific mechanisms to accomplish these effects vary from vasodilator to vasodilator.[citation needed
]

Class Description Example
Hyperpolarization-mediated (Calcium channel blocker) Changes in the
voltage-sensitive calcium channels
in the plasma membrane.
adenosine
cAMP-mediated Adrenergic stimulation results in elevated levels of cAMP and protein kinase A, which results in increasing calcium removal from the cytoplasm. prostacyclin
cGMP-mediated (Nitrovasodilator) Through stimulation of
protein kinase G
.
nitric oxide

PDE5 inhibitors and potassium channel openers can also have similar results.

Compounds that mediate the above mechanisms may be grouped as

exogenous
.

Causes

Endogenous

Vasodilators [24] Receptor
(↑ = opens. ↓ = closes)
vascular smooth muscle cells
if not otherwise specified
Transduction
(↑ = increases. ↓ = decreases) [24]
EDHF ?
VDCC
→ ↓intracellular Ca2+
PKG
activity →
  • phosphorylation of
    MLCK
    → ↓MLCK activity → dephosphorylation of MLC
  • SERCA → ↓intracellular Ca2+
NO receptor on endothelium
endothelin synthesis [25]
epinephrine
(adrenaline)
β-2 adrenergic receptor
MLCK
→ ↓MLCK activity → dephosphorylation of MLC
histamine histamine H2 receptor
prostacyclin
IP receptor
prostaglandin D2
DP receptor
prostaglandin E2
EP receptor
VIP VIP receptor
cAMP → ↑PKA
activity →
  • phosphorylation of
    MLCK
    → ↓MLCK activity → dephosphorylation of MLC
  • open
    VDCC
    → ↓intracellular Ca2+
(extracellular) adenosine
adenosine receptors
VDCC
→ ↓intracellular Ca2+
  • (extracellular) ATP
  • (extracellular) ADP
P2Y receptor activate
PLC activity → ↑intracellular Ca2+ → ↑NOS activity → ↑NO
→ (see nitric oxide)
L-arginine imidazoline and α-2 receptor?
Na+/K+-ATPase[26] → ↓intracellular Na+ → ↑Na+/Ca2+ exchanger
activity → ↓intracellular Ca2+
bradykinin bradykinin receptor
substance P
niacin
(as nicotinic acid only)
platelet-activating factor (PAF)
CO2 -
interstitial pH → ?[27]
interstitial lactic acid
(probably)
-
muscle work -
various receptors on endothelium endothelin synthesis [25]

The vasodilating action of activation of

beta-2 receptors (such as by adrenaline) appears to be endothelium-independent.[28]

Autonomic nervous system control

As referenced in the explanation of smooth muscle physiology, smooth muscle within the tunica media is innervated by the autonomic nervous system. The autonomic nervous system (ANS) controls essential involuntary body functions and originates as nerves leaving the brain stem or spinal cord; it contains both sensor and motor nerves.[2] The two divisions of the ANS, the sympathetic nervous system (SNS) and the parasympathetic nervous system (PSNS), impact blood vessels differently.[2] Traditionally we understand that these two divisions work against each other, the SNS producing "fight or flight" and the PSNS producing "rest and digest", but in the case of vascular innervation this line becomes blurred[6] ANS nerves do not directly innervate the vasculature via synapses with muscle cells; instead, they release neurotransmitters that reach target cells and effect smooth muscle contraction or relaxation.[6] Physical characteristics of the SNS and PSNS cause the SNS to have a prolonged, systemic impact on blood vessels, while the PSNS causes short-lived, localized change.[2] SNS stimulation causes a base level of vasoconstriction often referred to as basal neural tone, maintaining blood pressure.[2] Often vasodilation is simply the result of insufficient neurotransmitter to maintain basal neural tone, without the presence of a compound directly causing vasodilation.[2]

Neurotransmitters can act by binding directly to smooth muscle cells or by binding to endothelial cells mediating the effects of the neurotransmitter.[6] Below is a table summarizing major neurotransmitters involved in regulation of the vasculature.

Neurotransmitter Sympathetic or Parasympathetic Target Cells and Receptors Impact on Vasculature
norepinephrine (NE) sympathetic (mostly) adrenergic receptors α1, α2, β1, β2

α1- smooth muscle α2- endothelial β1, β2- smooth muscle

α1- increase concentration calcium ions, vasoconstricton[6]

α2- inhibit cAMP, release NO, vasodilation[6] β1, β2- possible vasodilation[6]

Acetylcholine (Ach) parasympathetic nicotonic Ach receptors (nAchRs)

muscanaric Ach receptors (mAchRs) - on both endothelial and smooth muscle cells[6]

nAchRs- modulate cytokines, counteract inflammation[6]

mAchRs- endothelial M3 AchR release NO, vasodlation smooth muscle M2 and M3 AchRs reduce release NO, vasoconstriction Note: Ach is quickly broken down, diffused, or undergoes reuptake, impacts are brief and localized[2]

Adenosine triphosphate (ATP) sympathetic purinergic receptors on smooth muscle and endothelial cells[6] smooth muscle- increase calcium ion concentration, vasoconstriction[6]

endothelium- possible role as mediator of hyperpolarization of smooth muscle cells[6] co-released with norepinephrine[2]

Neuropeptide Y (NPY) sympathetic receptors on endothelial cells causes vasoconstriction when co-released with norepinephrine[6]
CGRP
? CGRP1, CGRP2 receptors in endothelium[6] vasodilation, role in vascular dysfunction if levels are abnormal[6]

Also worthy of mention when discussing neural control of vasodilation is the renin-angiotensin-aldosterone system, or RAAS.[2] The kidneys retain water by reabsorbing sodium ions, or eliminate water by eliminating sodium ions.[29] Sympathetic nervous system activity, reduced blood volume or reduced arterial pressure trigger β-adrenergic receptors in select kidney cells[2] to release renin, which converts facilitates formation of angiotensin II from its substrate angiotensin.[29] Angiotensin II triggers adrenal glands to secrete aldosterone, a potent vasoconstrictor.[29]

Epinephrine, either exogenous or endogenous, is another vasoconstrictor released by the adrenal glands in response to stress.[29] It binds to α and β adrenergic receptors like norepinephrine, causing vasodilation and vasoconstriction in different body parts to redistribute circulation to critical areas.[2]

Cold-induced

Cold-induced vasodilation (CIVD) occurs after cold exposure, possibly to reduce the risk of injury. It can take place in several locations in the human body but is observed most often in the extremities. The fingers are especially common because they are exposed most often.[citation needed]

When the fingers are exposed to cold,

hot aches' which can be painful enough to bring on vomiting.[citation needed
]

A new phase of vasoconstriction follows the vasodilation, after which the process repeats itself. This is called the Hunting reaction. Experiments have shown that three other vascular responses to immersion of the finger in cold water are possible: a continuous state of vasoconstriction; slow, steady, and continuous rewarming; and a proportional control form in which the blood vessel diameter remains constant after an initial phase of vasoconstriction. However, the vast majority of responses can be classified as the Hunting reaction.[30]

Miscellaneous

Treatment

Direct vasodilation drugs

These drugs can keep vessels staying opened or help vessels refrain from being narrowed.[48]

Alpha-2A adrenergic receptor agonists

Drugs that appear to work by activating the α2A receptors in the brain thereby decreasing sympathetic nervous system activity.[49][48]

According to American Heart Association, Alpha-methyldopa may cause Orthostatic syncope as it exerts a greater blood pressure lowering effect when one is standing upright which may lead to feeling weak or fainting if the blood pressure has been lowered too far. Methyldopa's prominent side effects include drowsiness or sluggishness, dryness of the mouth, fever or anemia. Additionally to these, male patients may experience impotence.[48]
  • clonidine hydrochloride
  • guanabenz acetate
  • guanfacine hydrochloride
Clonidine, guanabenz or guanfacine may give rise to severe dryness of the mouth, constipation or drowsiness. Abrupt cessation taking may raise blood pressure quickly to dangerously high levels.[48]

Blood vessel muscle relaxants

Directly relax the muscle in the walls of the blood vessels (especially the arterioles), allowing the vessel to dilate (widen).[48]

Hydralazine may cause headaches, swelling around the eyes, heart palpitations or aches and pains in the joints. In clinical setting, hydralazine is not usually used alone.[48]
Minoxidil is a potent direct vasodilator used only in resistant severe high blood pressure or when kidney failure is present. Noted adverse effects comprise fluid retention (marked weight gain) and excessive hair growth.[48]

Therapeutic applications

Vasodilators are used to treat conditions such as

congestive heart failure, and erectile dysfunction, and where maintaining a lower blood pressure reduces the patient's risk of developing other cardiac problems.[50]
pulmonary arterial hypertension
(PAH).

See also

References

  1. ^ "Definition of Vasodilation". MedicineNet.com. 27 April 2011. Archived from the original on 5 January 2012. Retrieved 13 January 2012.
  2. ^
    PMID 21385998
    .
  3. ^ . Retrieved 22 March 2024.
  4. ^ .
  5. . Retrieved 22 March 2024.
  6. ^ .
  7. ^ .
  8. .
  9. .
  10. .
  11. ^ .
  12. ^ .
  13. ^ .
  14. ^ "What is volume flow rate? (article) | Fluids". Khan Academy. Retrieved 23 March 2024.
  15. PMID 34360549
    .
  16. . Retrieved 23 March 2024.
  17. ^ Klablunde RE (29 April 2008). "Therapeutic Uses of Vasodilators". CVPharmacology. Archived from the original on 16 December 2008. Retrieved 3 December 2013.
  18. PMID 32310535
    . Retrieved 23 March 2024.
  19. .
  20. .
  21. ^ "Definition of Vasodilation". MedicineNet.com. 27 April 2011. Archived from the original on 5 January 2012. Retrieved 13 January 2012.
  22. ^
    PMID 14627618
    .
  23. .
  24. ^ . Page 479
  25. ^ .
  26. .
  27. .
  28. .
  29. ^ .
  30. .
  31. .
  32. .
  33. . Retrieved 24 March 2024.
  34. .
  35. .
  36. .
  37. .
  38. . Retrieved 24 March 2024.
  39. . Retrieved 24 March 2024.
  40. .
  41. . Retrieved 24 March 2024.
  42. .
  43. .
  44. .
  45. .
  46. .
  47. .
  48. ^ a b c d e f g "Types of Blood Pressure Medications". www.heart.org. 31 October 2017. Archived from the original on 8 January 2019. Retrieved 2 May 2019.
  49. ^ "Guanfacine Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 18 March 2019.
  50. ^ Klablunde RE (29 April 2008). "Therapeutic Uses of Vasodilators". CVPharmacology. Archived from the original on 16 December 2008. Retrieved 3 December 2013.